Sign In
Buy MDGL
$512.88
+7.13 (+1.41%)
At Close: Jun 22, 2026
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Thursday, 05'th Feb 2026
CONSHOHOCKEN, Pa., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associ
Madrigal Pharmaceuticals to Release Fourth-Quarter and Full-Year 2025 Financial Results and Host Webcast on February 19, 2026
08:05am, Monday, 02'nd Feb 2026
CONSHOHOCKEN, Pa., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced today that it will release its fourth-quarter and full-year 2025 financial results on Thurs
STVN or MDGL: Which Is the Better Value Stock Right Now?
12:40pm, Monday, 26'th Jan 2026
Investors looking for stocks in the Medical - Drugs sector might want to consider either Stevanato Group (STVN) or Madrigal (MDGL). But which of these two stocks offers value investors a better bang f
Madrigal Pharmaceuticals, Inc. $MDGL Shares Purchased by Universal Beteiligungs und Servicegesellschaft mbH
05:50am, Monday, 26'th Jan 2026
Universal Beteiligungs und Servicegesellschaft mbH raised its position in Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) by 388.3% during the third quarter, according to the company in its most recent
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Thursday, 22'nd Jan 2026
CONSHOHOCKEN, Pa., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associ
Emerald Advisers LLC Sells 2,371 Shares of Madrigal Pharmaceuticals, Inc. $MDGL
04:53am, Thursday, 22'nd Jan 2026
Emerald Advisers LLC lowered its position in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) by 4.5% in the third quarter, according to its most recent disclosure with the SEC. The institution
Madrigal Pharmaceuticals Announces Grant of Inducement Award under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Wednesday, 21'st Jan 2026
CONSHOHOCKEN, Pa., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associ
Madrigal Pharmaceuticals (NASDAQ:MDGL) General Counsel Shannon Kelley Sells 692 Shares of Stock
05:08am, Wednesday, 21'st Jan 2026
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL - Get Free Report) General Counsel Shannon Kelley sold 692 shares of Madrigal Pharmaceuticals stock in a transaction on Tuesday, January 20th. The stock wa
Market Today: Boeing tops Airbus; Alphabet hits $4T
05:34pm, Tuesday, 13'th Jan 2026
Guru Stock PicksLarry Robbins has made the following transactions:Add in MYGN by 7.71%Stock News Trump floats 10% cap on card APRs: President Trump proposed a o
Madrigal Pharmaceuticals, Inc. (MDGL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
03:15am, Tuesday, 13'th Jan 2026
Madrigal Pharmaceuticals, Inc. (MDGL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
MDGL Secures Exclusive Global Right for MASH Treatment From PFE
12:20pm, Monday, 12'th Jan 2026
Madrigal Pharmaceuticals obtains global rights to Pfizer's ervogastat. It intends to pair it with Rezdiffra to advance combination therapies for MASH.
A wave of analyst downgrades, outlook resets and company-specific headlines pushed last week's biggest large-cap losers lower, led by First Solar, Roblox, and Madrigal.
Gladstone Institutional Advisory LLC Makes New Investment in Madrigal Pharmaceuticals, Inc. $MDGL
04:02am, Saturday, 10'th Jan 2026
Gladstone Institutional Advisory LLC acquired a new stake in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) during the third quarter, according to its most recent Form 13F filing with the Sec
Madrigal Expands its MASH Pipeline with Exclusive Global License Agreement for Ervogastat, a Phase 2 Oral DGAT-2 Inhibitor
08:00am, Friday, 09'th Jan 2026
CONSHOHOCKEN, Pa., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-assoc
UTHR or MDGL: Which Is the Better Value Stock Right Now?
12:40pm, Thursday, 08'th Jan 2026
Investors interested in stocks from the Medical - Drugs sector have probably already heard of United Therapeutics (UTHR) and Madrigal (MDGL). But which of these two companies is the best option for th
